ReproCELL was established in 2003 and was the first company that offered iPSC-derived human cardiomyocytes, hepatocytes and neuronal cells for research applications. They expanded their business by acquisitions of companies with knowledge and products for the upstream and downstream iPSC workflow.
The workflow consists of human tissues samples (BioServe), to iPSC reprogramming (Stemgent), cell differentiation (ReproCELL) and in vitro 3D cell tissue modelling (Reinnervate/Alvetex).

ReproCELL’s technologies, research reagents and services have applications in clinical diagnostics, drug screening and toxicity testing.

ReproCELL product brands

Human tissues »»
Stem cell technologies »»
3D cell bio-engineered tissue models »»

Major product lines

  • Stem cell technologies
  • Polystyrene scaffolds for 3D cell culture
  • iPS cell reprogramming
  • iPSC differentiated cells
  • Commercial biorepositories of tissue samples
  • Cell culture reagents

ReproCELL news

For more information, please visit: